NIH Guide: Weekly Index for January 14, 2022

Funding Opportunities

• Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
  (PAR-21-357)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
  (PAR-21-359)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
  (PAR-21-360)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
  (PAR-22-041)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
  (PAR-22-042)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Basic Experimental Studies Involving Humans Required)
  (PAR-22-043)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
  (PAR-22-044)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Required)
  (PAR-22-045)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Basic Experimental Studies Involving Humans Required)
  (PAR-22-046)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
  (PAR-22-060)
  National Institute of Dental and Craniofacial Research
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): January 7, 2025
• Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
  (PAR-22-090)
  National Cancer Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): December 10, 2024
• Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
  (PAR-22-091)
  National Cancer Institute
  Application Receipt Date(s): December 9, 2024
• Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional)
  (PAR-22-092)
  National Institute on Minority Health and Health Disparities
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  National Institute of Nursing Research
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovative ways to provide education on antimicrobial stewardship practices in animals (U01) Clinical Trial Not Allowed
  (PAR-22-108)
  Food and Drug Administration
  Application Receipt Date(s): May 2, 2022, by 11:59 PM Eastern Time. May 1, 2023, by 11:59 PM Eastern Time. May 1, 2024, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed)
  (RFA-AR-22-009)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): April 11, 2022
• Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
  (RFA-DA-22-037)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
  (RFA-DA-22-038)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• In Vitro Based Approaches to Evaluate the Bioequivalence of Prospective Generic Rectal and Vaginal Products (U01) Clinical Trial Not Allowed
  (RFA-FD-22-014)
  Food and Drug Administration
  Application Receipt Date(s): March 31, 2022
• In Vitro Approaches to Evaluate and Compare the Adhesion Performance of Transdermal and Topical Delivery Systems (TDS) (U01) Clinical Trial Required
  (RFA-FD-22-015)
  Food and Drug Administration
  Application Receipt Date(s): March 31, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Investigating the In Vivo Behavior and In Vitro Characteristics of a Purportedly Gastro-Retentive Extended Release Formulation to Elucidate Considerations Relevant to Generic Products (U01) Clinical Trials Required
  (RFA-FD-22-018)
  Food and Drug Administration
  Application Receipt Date(s): March 31, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Deconstruction of data and standards to support harmonization and interoperability with real world data for clinical research and regulatory submissions. (U01 Clinical Trial Not Allowed
  (RFA-FD-22-022)
  Food and Drug Administration
  Application Receipt Date(s): March 31, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• HEAL Initiative: National K12 Clinical Pain Career Development Program (K12 Clinical Trial Not Allowed)
  (RFA-NS-22-045)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): March 24, 2022
• HEAL Initiative: Coordinating Center for National Pain Scientists Career Development (R24 Clinical Trial Not Allowed)
  (RFA-NS-22-046)
  National Institute of Neurological Disorders and Stroke
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): March 24, 2022